Strategic acquisition of Duo-Med in Belgium

Strategic acquisition of Duo-Med in Belgium

ID: 6385

(Thomson Reuters ONE) - ARSEUS MEDICAL STRENGTHENS MARKET POSITION IN BELGIUM AND THE NETHERLANDSWaregem (Belgium), 30 September 2009 - Arseus has completed theacquisition of Duo-Med, a leading supplier of innovative medicaltechnology to hospitals in the Benelux. Duo-Med realised turnover ofapproximately ?6 million in 2008, with a double digit EBITDA margin.The acquisition will make a positive contribution to Arseus Medical'sprofitability.The acquisition of Duo-Med is consistent with Arseus Medical'sstrategy of focusing on offering highly distinctive medical productswith substantial added value. Duo-Med specialises in niche productsused in open and minimally invasive abdominal, gynaecological andurological surgery. Duo-Med also has a well-filled pipeline of newtechnologies, offering high added value, in growth markets such asobesity, micro laparoscopy and colorectal surgery. Duo-Med's productrange perfectly complements Arseus Medical's offerings.Mario Huyghe, CEO of Arseus Medical: 'The acquisition of Duo-Med fitsperfectly with Arseus Medical's growth strategy, focusing onexclusive distributorships for high added value products in healthcare. Many of Duo-Med's distributions are also exclusive for theBenelux, creating immediate opportunities to launch thesehigh-quality medical products, which have been such a success inBelgium, in the Netherlands as well via the Arseus Medical team. Thiswill enable us to accelerate the growth of our business in the Dutchmarket.'Ger van Jeveren, CEO of Arseus: 'The Duo-Med acquisition will advanceand reinforce Arseus Medical's leading position in the Benelux and isconsistent with the strategy adopted in 2009. It will pave the wayfor Arseus Medical's sustained growth as a focused distributor ofhigh-quality medical solutions and consumables.'Duo-Med's results will be included in the consolidation with effectfrom 1 September 2009.This is a translation of the Dutch press release; the Dutch pressrelease prevails.Please open the link below for the full press release:http://hugin.info/138311/R/1344794/322573.pdfThis announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.



Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Crucell Strengthens its Vaccine Sales in the UK with a Dedicated
Marketing and Sales Organization UCB launches an offer of up to EUR 350 million convertible bonds, due
2015
Bereitgestellt von Benutzer: hugin
Datum: 30.09.2009 - 07:45 Uhr
Sprache: Deutsch
News-ID 6385
Anzahl Zeichen: 0

contact information:
Town:

London



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 330 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Strategic acquisition of Duo-Med in Belgium"
steht unter der journalistisch-redaktionellen Verantwortung von

Arseus (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Arseus



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z